Esophageal Cancer Risk Registry

RecruitingOBSERVATIONAL
Enrollment

7,000

Participants

Timeline

Start Date

June 30, 1999

Primary Completion Date

December 31, 2050

Study Completion Date

December 31, 2050

Conditions
Esophageal CancerGastroesophageal Reflux Disease (GERD)Esophageal DiseasesHiatal HerniaEsophageal Achalasia
Interventions
PROCEDURE

Survey of client health, personal habits, family history

A questionnaire is administered at the time of consent.

PROCEDURE

Blood specimen for non-DNA and DNA parts

Blood specimen is collected prior to surgery or at the time of scheduled routine surgical procedure(s), and at the time of routine follow-up visits

PROCEDURE

Biopsy of esophageal/stomach tissue, lymph nodes, tumor

Tissue from the biopsies is collected intraoperatively.

PROCEDURE

Biopsies, oral (saliva) and/or secretions, washings or mucosal scrapings/brushing from routine clinical surveillance endoscopies

Tissue from the biopsies, oral (saliva) and/or secretions, washings or mucosal scrapings/brushings are collected intraoperatively.

Trial Locations (1)

15232

RECRUITING

Department of Cardiothoracic Surgery, Pittsburgh

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Cancer Institute (NCI)

NIH

lead

University of Pittsburgh

OTHER

NCT00260585 - Esophageal Cancer Risk Registry | Biotech Hunter | Biotech Hunter